Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept in adolescent psoriasis
NCT00808223Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2009
- Primary completion
- Feb 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of alefacept in plaque psoriasis, sponsored by Astellas Pharma. Started Apr 2009; status: completed.
02
Drugs
alefacept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00808223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808223.